Larimar Therapeutics (LRMR) Interest Coverage Ratio (2013 - 2025)
Larimar Therapeutics (LRMR) posted Interest Coverage Ratio of 42.68 for Q4 2025, down 2.43% on a QoQ basis from 41.67 in Q3 2025, and down 23498.26% year-over-year from N/an in Q4 2024.
Larimar Therapeutics (LRMR) Interest Coverage Ratio (2013 - 2025) Analysis & Trends
Larimar Therapeutics' Interest Coverage Ratio history runs 13 years deep, the most recent figure standing at 42.68 for Q4 2025.
- Quarterly Interest Coverage Ratio fell 23498.26% year-over-year to 42.68 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 115.0 (down 21792.26% YoY) and the FY2025 annual result came in at 115.0, down 21792.26% from the prior year.
- Interest Coverage Ratio was 42.68 for Q4 2025 at Larimar Therapeutics, down from 41.67 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.07 in Q4 2021 and bottomed at 42.68 in Q4 2025.
- A 5-year average of 7.14 and a median of 1.99 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio jumped 86.58% — and 2025, when it sank 23498.26%.
- Larimar Therapeutics' Interest Coverage Ratio stood at 0.07 in 2021, then dropped by 8.91% to 0.08 in 2022, then fell by 25.2% to 0.1 in 2023, then plunged by 81.05% to 0.18 in 2024, then sank by 23498.26% to 42.68 in 2025.
- Business Quant data shows LRMR's Interest Coverage Ratio at 42.68 in Q4 2025, 41.67 in Q3 2025, and 23.39 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | -42.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42.68 |
| Sep 30, 2025 | -41.67 |
| Jun 30, 2025 | -23.39 |
| Mar 31, 2025 | -5.16 |
| Dec 31, 2024 | -0.18 |
| Sep 30, 2024 | -2.47 |
| Jun 30, 2024 | -2.51 |
| Mar 31, 2024 | -1.52 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -1.42 |
| Jun 30, 2023 | -1.37 |
| Mar 31, 2023 | -3.71 |
| Dec 31, 2022 | -0.08 |
| Sep 30, 2022 | -3.63 |
| Jun 30, 2022 | -3.48 |
| Mar 31, 2022 | -1.04 |
| Dec 31, 2021 | -0.07 |
| Sep 30, 2021 | -5.65 |
| Jun 30, 2021 | -1.34 |
| Mar 31, 2021 | -1.25 |